APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transdermal Drug Patches

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

Selected research

Market Structure

Global Transdermal Drug Patches Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025197 pages

Choose your research edition.

Industry ResearchTransdermal Drug Patches Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Transdermal Drug Patches Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Transdermal Drug Patches Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transdermal Drug Patches Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Transdermal Drug Patches Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

The major players in global Transdermal Drug Patches market include Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan, etc. The top 3 players occupy about 35% shares of the global market. America and Europe are main markets, they occupy about 75% of the global market. Methyl Salicylate-based Patch is the main type, with a share over 15%. Rx Channel is the main application, which holds a share about 90%.

This report provides an overview of the global Transdermal Drug Patches market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Transdermal Drug Patches and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Transdermal Drug Patches sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Transdermal Drug Patches market size, projected growth trends, production technologies, key applications, and end-use industries.

Transdermal Drug Patches Segment by Company

Hisamitsu Pharmaceutical

Johnson & Johnson

Novartis

UCB Pharma

Mylan

Teva Pharmaceutical

Nitto Denko

Grünenthal

IBSA Group

GSK

Luye Pharma Group

Pfizer

Chattem

Dr Reddy’s Laboratories

Bayer

Mundipharma

Endo International

Beijing Tide Pharmaceutical

Transdermal Drug Patches Segment by Type

Methyl Salicylate-based Patch

Rivastigmine Transdermal Patch

Fentanyl Transdermal Patch

Lidocaine Patch

Diclofenac Patch

Nicotine Transdermal Patch

Others

Transdermal Drug Patches Segment by Application

Rx Channel

OTC Channel

Transdermal Drug Patches Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Drug Patches market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transdermal Drug Patches and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Drug Patches.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Transdermal Drug Patches market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Transdermal Drug Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Transdermal Drug Patches in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Transdermal Drug Patches in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Transdermal Drug Patches Industry Trends Table 2. Transdermal Drug Patches Industry Drivers Table 3. Transdermal Drug Patches Industry Opportunities and Challenges Table 4. Transdermal Drug Patches Industry Restraints Table 5. Global Transdermal Drug Patches Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Transdermal Drug Patches Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Transdermal Drug Patches Sales by Manufacturers (M Pcs) & (2021-2026) Table 8. Global Transdermal Drug Patches Sales Market Share by Manufacturers Table 9. Global Transdermal Drug Patches Average Sales Price (US$/Pc) of Manufacturers (2021-2026) Table 10. Global Transdermal Drug Patches Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Transdermal Drug Patches Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Transdermal Drug Patches Manufacturers, Product Type & Application Table 13. Global Transdermal Drug Patches Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Transdermal Drug Patches by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Methyl Salicylate-based Patch Table 17. Major Manufacturers of Rivastigmine Transdermal Patch Table 18. Major Manufacturers of Fentanyl Transdermal Patch Table 19. Major Manufacturers of Lidocaine Patch Table 20. Major Manufacturers of Diclofenac Patch Table 21. Major Manufacturers of Nicotine Transdermal Patch Table 22. Major Manufacturers of Others Table 23. Global Transdermal Drug Patches Sales by Type 2021 VS 2025 VS 2032 (M Pcs) Table 24. Global Transdermal Drug Patches Sales by Type (2021-2026) & (M Pcs) Table 25. Global Transdermal Drug Patches Sales by Type (2027-2032) & (M Pcs) Table 26. Global Transdermal Drug Patches Sales Market Share by Type (2021-2026) Table 27. Global Transdermal Drug Patches Sales Market Share by Type (2027-2032) Table 28. Global Transdermal Drug Patches Revenue by Type 2021 VS 2025 VS 2032 (M Pcs) Table 29. Global Transdermal Drug Patches Revenue by Type (2021-2026) & (M Pcs) Table 30. Global Transdermal Drug Patches Revenue by Type (2027-2032) & (M Pcs) Table 31. Global Transdermal Drug Patches Revenue Market Share by Type (2021-2026) Table 32. Global Transdermal Drug Patches Revenue Market Share by Type (2027-2032) Table 33. Major Manufacturers of Rx Channel Table 34. Major Manufacturers of OTC Channel Table 35. Global Transdermal Drug Patches Sales by Application 2021 VS 2025 VS 2032 (M Pcs) Table 36. Global Transdermal Drug Patches Sales by Application (2021-2026) & (M Pcs) Table 37. Global Transdermal Drug Patches Sales by Application (2027-2032) & (M Pcs) Table 38. Global Transdermal Drug Patches Sales Market Share by Application (2021-2026) Table 39. Global Transdermal Drug Patches Sales Market Share by Application (2027-2032) Table 40. Global Transdermal Drug Patches Revenue by Application 2021 VS 2025 VS 2032 (M Pcs) Table 41. Global Transdermal Drug Patches Revenue by Application (2021-2026) & (M Pcs) Table 42. Global Transdermal Drug Patches Revenue by Application (2027-2032) & (M Pcs) Table 43. Global Transdermal Drug Patches Revenue Market Share by Application (2021-2026) Table 44. Global Transdermal Drug Patches Revenue Market Share by Application (2027-2032) Table 45. Global Transdermal Drug Patches Sales by Region: 2021 VS 2025 VS 2032 (M Pcs) Table 46. Global Transdermal Drug Patches Sales by Region (2021-2026) & (M Pcs) Table 47. Global Transdermal Drug Patches Sales Market Share by Region (2021-2026) Table 48. Global Transdermal Drug Patches Sales Forecasted by Region (2027-2032) & (M Pcs) Table 49. Global Transdermal Drug Patches Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Transdermal Drug Patches Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Pcs) Table 51. North America Transdermal Drug Patches Sales by Country (2021-2026) & (M Pcs) Table 52. North America Transdermal Drug Patches Sales by Country (2027-2032) & (M Pcs) Table 53. Europe Transdermal Drug Patches Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Pcs) Table 54. Europe Transdermal Drug Patches Sales by Country (2021-2026) & (M Pcs) Table 55. Europe Transdermal Drug Patches Sales by Country (2027-2032) & (M Pcs) Table 56. Asia Pacific Transdermal Drug Patches Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Pcs) Table 57. Asia Pacific Transdermal Drug Patches Sales by Country (2021-2026) & (M Pcs) Table 58. Asia Pacific Transdermal Drug Patches Sales by Country (2027-2032) & (M Pcs) Table 59. South America, Middle East and Africa Transdermal Drug Patches Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Pcs) Table 60. South America, Middle East and Africa Transdermal Drug Patches Sales by Country (2021-2026) & (M Pcs) Table 61. South America, Middle East and Africa Transdermal Drug Patches Sales by Country (2027-2032) & (M Pcs) Table 62. Global Transdermal Drug Patches Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Transdermal Drug Patches Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Transdermal Drug Patches Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Transdermal Drug Patches Revenue Market Share by Region (2021-2026) Table 66. Global Transdermal Drug Patches Revenue Market Share by Region (2027-2032) Table 67. Hisamitsu Pharmaceutical Company Information Table 68. Hisamitsu Pharmaceutical Business Overview Table 69. Hisamitsu Pharmaceutical Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Hisamitsu Pharmaceutical Transdermal Drug Patches Product Portfolio Table 71. Hisamitsu Pharmaceutical Recent Development Table 72. Johnson & Johnson Company Information Table 73. Johnson & Johnson Business Overview Table 74. Johnson & Johnson Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Johnson & Johnson Transdermal Drug Patches Product Portfolio Table 76. Johnson & Johnson Recent Development Table 77. Novartis Company Information Table 78. Novartis Business Overview Table 79. Novartis Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Novartis Transdermal Drug Patches Product Portfolio Table 81. Novartis Recent Development Table 82. UCB Pharma Company Information Table 83. UCB Pharma Business Overview Table 84. UCB Pharma Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. UCB Pharma Transdermal Drug Patches Product Portfolio Table 86. UCB Pharma Recent Development Table 87. Mylan Company Information Table 88. Mylan Business Overview Table 89. Mylan Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Mylan Transdermal Drug Patches Product Portfolio Table 91. Mylan Recent Development Table 92. Teva Pharmaceutical Company Information Table 93. Teva Pharmaceutical Business Overview Table 94. Teva Pharmaceutical Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Teva Pharmaceutical Transdermal Drug Patches Product Portfolio Table 96. Teva Pharmaceutical Recent Development Table 97. Nitto Denko Company Information Table 98. Nitto Denko Business Overview Table 99. Nitto Denko Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Nitto Denko Transdermal Drug Patches Product Portfolio Table 101. Nitto Denko Recent Development Table 102. Grünenthal Company Information Table 103. Grünenthal Business Overview Table 104. Grünenthal Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Grünenthal Transdermal Drug Patches Product Portfolio Table 106. Grünenthal Recent Development Table 107. IBSA Group Company Information Table 108. IBSA Group Business Overview Table 109. IBSA Group Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. IBSA Group Transdermal Drug Patches Product Portfolio Table 111. IBSA Group Recent Development Table 112. GSK Company Information Table 113. GSK Business Overview Table 114. GSK Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. GSK Transdermal Drug Patches Product Portfolio Table 116. GSK Recent Development Table 117. Luye Pharma Group Company Information Table 118. Luye Pharma Group Business Overview Table 119. Luye Pharma Group Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Luye Pharma Group Transdermal Drug Patches Product Portfolio Table 121. Luye Pharma Group Recent Development Table 122. Pfizer Company Information Table 123. Pfizer Business Overview Table 124. Pfizer Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Pfizer Transdermal Drug Patches Product Portfolio Table 126. Pfizer Recent Development Table 127. Chattem Company Information Table 128. Chattem Business Overview Table 129. Chattem Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Chattem Transdermal Drug Patches Product Portfolio Table 131. Chattem Recent Development Table 132. Dr Reddy’s Laboratories Company Information Table 133. Dr Reddy’s Laboratories Business Overview Table 134. Dr Reddy’s Laboratories Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Dr Reddy’s Laboratories Transdermal Drug Patches Product Portfolio Table 136. Dr Reddy’s Laboratories Recent Development Table 137. Bayer Company Information Table 138. Bayer Business Overview Table 139. Bayer Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Bayer Transdermal Drug Patches Product Portfolio Table 141. Bayer Recent Development Table 142. Mundipharma Company Information Table 143. Mundipharma Business Overview Table 144. Mundipharma Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Mundipharma Transdermal Drug Patches Product Portfolio Table 146. Mundipharma Recent Development Table 147. Endo International Company Information Table 148. Endo International Business Overview Table 149. Endo International Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. Endo International Transdermal Drug Patches Product Portfolio Table 151. Endo International Recent Development Table 152. Beijing Tide Pharmaceutical Company Information Table 153. Beijing Tide Pharmaceutical Business Overview Table 154. Beijing Tide Pharmaceutical Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 155. Beijing Tide Pharmaceutical Transdermal Drug Patches Product Portfolio Table 156. Beijing Tide Pharmaceutical Recent Development Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Transdermal Drug Patches Distributors List Table 160. Transdermal Drug Patches Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Transdermal Drug Patches Product Image Figure 2. Global Transdermal Drug Patches Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transdermal Drug Patches Market Size (2021-2032) & (US$ Million) Figure 4. Global Transdermal Drug Patches Sales (2021-2032) & (M Pcs) Figure 5. Global Transdermal Drug Patches Average Price (US$/Pc) & (2021-2032) Figure 6. Global Top 5 and 10 Transdermal Drug Patches Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Methyl Salicylate-based Patch Image Figure 9. Rivastigmine Transdermal Patch Image Figure 10. Fentanyl Transdermal Patch Image Figure 11. Lidocaine Patch Image Figure 12. Diclofenac Patch Image Figure 13. Nicotine Transdermal Patch Image Figure 14. Others Image Figure 15. Global Transdermal Drug Patches Sales by Type (2021 VS 2025 VS 2032) & (M Pcs) Figure 16. Global Transdermal Drug Patches Sales Market Share 2021 VS 2025 VS 2032 Figure 17. Global Transdermal Drug Patches Sales Market Share by Type (2021-2032) Figure 18. Global Transdermal Drug Patches Revenue by Type (2021 VS 2025 VS 2032) & (M Pcs) Figure 19. Global Transdermal Drug Patches Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Transdermal Drug Patches Revenue Market Share by Type (2021-2032) Figure 21. Rx Channel Image Figure 22. OTC Channel Image Figure 23. Global Transdermal Drug Patches Sales by Application (2021 VS 2025 VS 2032) & (M Pcs) Figure 24. Global Transdermal Drug Patches Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Transdermal Drug Patches Sales Market Share by Application (2021-2032) Figure 26. Global Transdermal Drug Patches Revenue by Application (2021 VS 2025 VS 2032) & (M Pcs) Figure 27. Global Transdermal Drug Patches Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Transdermal Drug Patches Revenue Market Share by Application (2021-2032) Figure 29. North America Transdermal Drug Patches Sales and Growth Rate (2021-2032) & (M Pcs) Figure 30. North America Transdermal Drug Patches Sales Market Share by Country (2021-2032) Figure 31. U.S. Transdermal Drug Patches Sales and Growth Rate (2021-2032) & (M Pcs) Figure 32. Canada Transdermal Drug Patches Sales and Growth Rate (2021-2032) & (M Pcs) Figure 33. Mexico Transdermal Drug Patches Sales and Growth Rate (2021-2032) & (M Pcs) Figure 34. Europe Transdermal Drug Patches Sales and Growth Rate (2021-2032) & (M Pcs) Figure 35. Europe Transdermal Drug Patches Sales Market Share by Country (2021-2032) Figure 36. Germany Transdermal Drug Patches Sales and Growth Rate (2021-2032) & (M Pcs) Figure 37. France Transdermal Drug Patches Sales and Growth Rate (2021-2032) & (M Pcs) Figure 38. U.K. Transdermal Drug Patches Sales and Growth Rate (2021-2032) & (M Pcs) Figure 39. Italy Transdermal Drug Patches Sales and Growth Rate (2021-2032) & (M Pcs) Figure 40. Netherlands Transdermal Drug Patches Sales and Growth Rate (2021-2032) & (M Pcs) Figure 41. Asia Pacific Transdermal Drug Patches Sales and Growth Rate (2021-2032) & (M Pcs) Figure 42. Asia Pacific Transdermal Drug Patches Sales Market Share by Country (2021-2032) Figure 43. China Transdermal Drug Patches Sales and Growth Rate (2021-2032) & (M Pcs) Figure 44. Japan Transdermal Drug Patches Sales and Growth Rate (2021-2032) & (M Pcs) Figure 45. South Korea Transdermal Drug Patches Sales and Growth Rate (2021-2032) & (M Pcs) Figure 46. Southeast Asia Transdermal Drug Patches Sales and Growth Rate (2021-2032) & (M Pcs) Figure 47. India Transdermal Drug Patches Sales and Growth Rate (2021-2032) & (M Pcs) Figure 48. Australia Transdermal Drug Patches Sales and Growth Rate (2021-2032) & (M Pcs) Figure 49. South America, Middle East and Africa Transdermal Drug Patches Sales and Growth Rate (2021-2032) & (M Pcs) Figure 50. South America, Middle East and Africa Transdermal Drug Patches Sales Market Share by Country (2021-2032) Figure 51. Brazil Transdermal Drug Patches Sales and Growth Rate (2021-2032) & (M Pcs) Figure 52. South Africa Transdermal Drug Patches Sales and Growth Rate (2021-2032) & (M Pcs) Figure 53. Saudi Arabia Transdermal Drug Patches Sales and Growth Rate (2021-2032) & (M Pcs) Figure 54. Turkey Transdermal Drug Patches Sales and Growth Rate (2021-2032) & (M Pcs) Figure 55. Argentina Transdermal Drug Patches Sales and Growth Rate (2021-2032) & (M Pcs) Figure 56. UAE Transdermal Drug Patches Sales and Growth Rate (2021-2032) & (M Pcs) Figure 57. Egypt Transdermal Drug Patches Sales and Growth Rate (2021-2032) & (M Pcs) Figure 58. Chile Transdermal Drug Patches Sales and Growth Rate (2021-2032) & (M Pcs) Figure 59. Global Transdermal Drug Patches Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Transdermal Drug Patches Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Transdermal Drug Patches Revenue (2021-2032) & (US$ Million) Figure 62. North America Transdermal Drug Patches Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Transdermal Drug Patches Revenue (2021-2032) & (US$ Million) Figure 64. Europe Transdermal Drug Patches Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Transdermal Drug Patches Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Transdermal Drug Patches Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Transdermal Drug Patches Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Transdermal Drug Patches Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Transdermal Drug Patches Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Transdermal Drug Patches Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Methyl Salicylate-based Patch
  • Rivastigmine Transdermal Patch
  • Fentanyl Transdermal Patch
  • Lidocaine Patch
  • Diclofenac Patch
  • Nicotine Transdermal Patch
  • Others
Applications
  • Rx Channel
  • OTC Channel
Companies covered
  • Hisamitsu Pharmaceutical
  • Johnson & Johnson
  • Novartis
  • UCB Pharma
  • Mylan
  • Teva Pharmaceutical
  • Nitto Denko
  • Grünenthal
  • IBSA Group
  • GSK
  • Luye Pharma Group
  • Pfizer
  • Chattem
  • Dr Reddy’s Laboratories
  • Bayer
  • Mundipharma
  • Endo International
  • Beijing Tide Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Transdermal Drug Patches Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Transdermal Drug Patches Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Transdermal Drug Patches Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Transdermal Drug Patches Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Transdermal Drug Patches Market Dynamics
  1. 2.1 Transdermal Drug Patches Industry Trends
  2. 2.2 Transdermal Drug Patches Industry Drivers
  3. 2.3 Transdermal Drug Patches Industry Opportunities and Challenges
  4. 2.4 Transdermal Drug Patches Industry Restraints
3 Transdermal Drug Patches Market by Manufacturers
  1. 3.1 Global Transdermal Drug Patches Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Transdermal Drug Patches Sales by Manufacturers (2021-2026)
  3. 3.3 Global Transdermal Drug Patches Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Transdermal Drug Patches Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Transdermal Drug Patches Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Transdermal Drug Patches Manufacturers, Product Type & Application
  7. 3.7 Global Transdermal Drug Patches Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Transdermal Drug Patches Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Transdermal Drug Patches Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Transdermal Drug Patches Tier 1, Tier 2, and Tier 3
4 Transdermal Drug Patches Market by Type
  1. 4.1 Transdermal Drug Patches Type Introduction
  2. 4.1.1 Methyl Salicylate-based Patch
  3. 4.1.2 Rivastigmine Transdermal Patch
  4. 4.1.3 Fentanyl Transdermal Patch
  5. 4.1.4 Lidocaine Patch
  6. 4.1.5 Diclofenac Patch
  7. 4.1.6 Nicotine Transdermal Patch
  8. 4.1.7 Others
  9. 4.2 Global Transdermal Drug Patches Sales by Type
  10. 4.2.1 Global Transdermal Drug Patches Sales by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Transdermal Drug Patches Sales by Type (2021-2032)
  12. 4.2.3 Global Transdermal Drug Patches Sales Market Share by Type (2021-2032)
  13. 4.3 Global Transdermal Drug Patches Revenue by Type
  14. 4.3.1 Global Transdermal Drug Patches Revenue by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Transdermal Drug Patches Revenue by Type (2021-2032)
  16. 4.3.3 Global Transdermal Drug Patches Revenue Market Share by Type (2021-2032)
5 Transdermal Drug Patches Market by Application
  1. 5.1 Transdermal Drug Patches Application Introduction
  2. 5.1.1 Rx Channel
  3. 5.1.2 OTC Channel
  4. 5.2 Global Transdermal Drug Patches Sales by Application
  5. 5.2.1 Global Transdermal Drug Patches Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Transdermal Drug Patches Sales by Application (2021-2032)
  7. 5.2.3 Global Transdermal Drug Patches Sales Market Share by Application (2021-2032)
  8. 5.3 Global Transdermal Drug Patches Revenue by Application
  9. 5.3.1 Global Transdermal Drug Patches Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Transdermal Drug Patches Revenue by Application (2021-2032)
  11. 5.3.3 Global Transdermal Drug Patches Revenue Market Share by Application (2021-2032)
6 Global Transdermal Drug Patches Sales by Region
  1. 6.1 Global Transdermal Drug Patches Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Transdermal Drug Patches Sales by Region (2021-2032)
  3. 6.2.1 Global Transdermal Drug Patches Sales by Region (2021-2026)
  4. 6.2.2 Global Transdermal Drug Patches Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Transdermal Drug Patches Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Transdermal Drug Patches Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Transdermal Drug Patches Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Transdermal Drug Patches Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Transdermal Drug Patches Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Transdermal Drug Patches Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Transdermal Drug Patches Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Transdermal Drug Patches Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Transdermal Drug Patches Revenue by Region
  1. 7.1 Global Transdermal Drug Patches Revenue by Region
  2. 7.1.1 Global Transdermal Drug Patches Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Transdermal Drug Patches Revenue by Region (2021-2026)
  4. 7.1.3 Global Transdermal Drug Patches Revenue by Region (2027-2032)
  5. 7.1.4 Global Transdermal Drug Patches Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Transdermal Drug Patches Revenue (2021-2032)
  8. 7.2.2 North America Transdermal Drug Patches Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Transdermal Drug Patches Revenue (2021-2032)
  11. 7.3.2 Europe Transdermal Drug Patches Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Transdermal Drug Patches Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Transdermal Drug Patches Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Transdermal Drug Patches Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Transdermal Drug Patches Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Hisamitsu Pharmaceutical
  2. 8.1.1 Hisamitsu Pharmaceutical Company Information
  3. 8.1.2 Hisamitsu Pharmaceutical Business Overview
  4. 8.1.3 Hisamitsu Pharmaceutical Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Hisamitsu Pharmaceutical Transdermal Drug Patches Product Portfolio
  6. 8.1.5 Hisamitsu Pharmaceutical Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Transdermal Drug Patches Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Transdermal Drug Patches Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 UCB Pharma
  20. 8.4.1 UCB Pharma Company Information
  21. 8.4.2 UCB Pharma Business Overview
  22. 8.4.3 UCB Pharma Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 UCB Pharma Transdermal Drug Patches Product Portfolio
  24. 8.4.5 UCB Pharma Recent Developments
  25. 8.5 Mylan
  26. 8.5.1 Mylan Company Information
  27. 8.5.2 Mylan Business Overview
  28. 8.5.3 Mylan Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Mylan Transdermal Drug Patches Product Portfolio
  30. 8.5.5 Mylan Recent Developments
  31. 8.6 Teva Pharmaceutical
  32. 8.6.1 Teva Pharmaceutical Company Information
  33. 8.6.2 Teva Pharmaceutical Business Overview
  34. 8.6.3 Teva Pharmaceutical Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Teva Pharmaceutical Transdermal Drug Patches Product Portfolio
  36. 8.6.5 Teva Pharmaceutical Recent Developments
  37. 8.7 Nitto Denko
  38. 8.7.1 Nitto Denko Company Information
  39. 8.7.2 Nitto Denko Business Overview
  40. 8.7.3 Nitto Denko Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Nitto Denko Transdermal Drug Patches Product Portfolio
  42. 8.7.5 Nitto Denko Recent Developments
  43. 8.8 Grünenthal
  44. 8.8.1 Grünenthal Company Information
  45. 8.8.2 Grünenthal Business Overview
  46. 8.8.3 Grünenthal Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Grünenthal Transdermal Drug Patches Product Portfolio
  48. 8.8.5 Grünenthal Recent Developments
  49. 8.9 IBSA Group
  50. 8.9.1 IBSA Group Company Information
  51. 8.9.2 IBSA Group Business Overview
  52. 8.9.3 IBSA Group Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 IBSA Group Transdermal Drug Patches Product Portfolio
  54. 8.9.5 IBSA Group Recent Developments
  55. 8.10 GSK
  56. 8.10.1 GSK Company Information
  57. 8.10.2 GSK Business Overview
  58. 8.10.3 GSK Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 GSK Transdermal Drug Patches Product Portfolio
  60. 8.10.5 GSK Recent Developments
  61. 8.11 Luye Pharma Group
  62. 8.11.1 Luye Pharma Group Company Information
  63. 8.11.2 Luye Pharma Group Business Overview
  64. 8.11.3 Luye Pharma Group Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Luye Pharma Group Transdermal Drug Patches Product Portfolio
  66. 8.11.5 Luye Pharma Group Recent Developments
  67. 8.12 Pfizer
  68. 8.12.1 Pfizer Company Information
  69. 8.12.2 Pfizer Business Overview
  70. 8.12.3 Pfizer Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Pfizer Transdermal Drug Patches Product Portfolio
  72. 8.12.5 Pfizer Recent Developments
  73. 8.13 Chattem
  74. 8.13.1 Chattem Company Information
  75. 8.13.2 Chattem Business Overview
  76. 8.13.3 Chattem Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Chattem Transdermal Drug Patches Product Portfolio
  78. 8.13.5 Chattem Recent Developments
  79. 8.14 Dr Reddy’s Laboratories
  80. 8.14.1 Dr Reddy’s Laboratories Company Information
  81. 8.14.2 Dr Reddy’s Laboratories Business Overview
  82. 8.14.3 Dr Reddy’s Laboratories Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Dr Reddy’s Laboratories Transdermal Drug Patches Product Portfolio
  84. 8.14.5 Dr Reddy’s Laboratories Recent Developments
  85. 8.15 Bayer
  86. 8.15.1 Bayer Company Information
  87. 8.15.2 Bayer Business Overview
  88. 8.15.3 Bayer Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Bayer Transdermal Drug Patches Product Portfolio
  90. 8.15.5 Bayer Recent Developments
  91. 8.16 Mundipharma
  92. 8.16.1 Mundipharma Company Information
  93. 8.16.2 Mundipharma Business Overview
  94. 8.16.3 Mundipharma Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Mundipharma Transdermal Drug Patches Product Portfolio
  96. 8.16.5 Mundipharma Recent Developments
  97. 8.17 Endo International
  98. 8.17.1 Endo International Company Information
  99. 8.17.2 Endo International Business Overview
  100. 8.17.3 Endo International Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Endo International Transdermal Drug Patches Product Portfolio
  102. 8.17.5 Endo International Recent Developments
  103. 8.18 Beijing Tide Pharmaceutical
  104. 8.18.1 Beijing Tide Pharmaceutical Company Information
  105. 8.18.2 Beijing Tide Pharmaceutical Business Overview
  106. 8.18.3 Beijing Tide Pharmaceutical Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Beijing Tide Pharmaceutical Transdermal Drug Patches Product Portfolio
  108. 8.18.5 Beijing Tide Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Transdermal Drug Patches Value Chain Analysis
  2. 9.1.1 Transdermal Drug Patches Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Transdermal Drug Patches Production Mode & Process
  6. 9.2 Transdermal Drug Patches Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Transdermal Drug Patches Distributors
  9. 9.2.3 Transdermal Drug Patches Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst